SCHEMBL5726364

SCHEMBL5726364

CCOC(=O)CSc1ncc(Cc2ccccc2)c(N)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 3/20 0.60
▸ ALDH1A1 P00352 6/20 0.56
▸ SMN1; SMN2 Q16637 5/20 0.56
▸ NPC1 O15118 3/20 0.56
▸ RAB9A P51151 3/20 0.56
▸ TSHR P16473 2/20 0.56
▸ NFKB1 P19838 1/20 0.56
▸ NFKB2 Q00653 1/20 0.56
▸ RELA Q04206 1/20 0.56
▸ MAPT P10636 4/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ MAPK1 P28482 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ PRNP P04156 1/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5726443 0.89 ALDH1A1 (0.49) ABCB1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5726381 0.86 ALDH1A1 (0.48) ABCB1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5726497 0.86 ABCB1 (0.48) ABCB1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5726586 0.86 ALDH1A1 (0.45) ABCB1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5726488 0.86 RAB9A (0.43) ABCB1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5726382 0.85 ALDH1A1 (0.43) ABCB1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5726292 0.84 ALDH1A1 (0.43) ABCB1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5726116 0.84 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2NPC1RAB9ATSHR
SCHEMBL5727273 0.84 ALDH1A1 (0.42) ABCB1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5726230 0.83 SMN1; SMN2 (0.43) ABCB1ALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1395568-B1 4-AMINOPYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-11-02 — — EP claimed
EP-1395568-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-03-10 — — EP claimed
US-20030022907-A1 4-aminopyrimidine derivatives HOFFMANN-LA ROCHE INC. 2003-01-30 — — US claimed
WO-2002094795-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-11-28 — — WO claimed
US-7138404-B2 4-aminopyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-21 — — US disclosed
EP-1395568-B1 4-AMINOPYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-11-02 — — EP disclosed
EP-1395568-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-03-10 — — EP disclosed
US-20030022907-A1 4-aminopyrimidine derivatives HOFFMANN-LA ROCHE INC. 2003-01-30 — — US disclosed
WO-2002094795-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-11-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030022907-A1 4-aminopyrimidine derivatives GRM5, GRIK5, GRM1 ABCB1 510/4885ALDH1A1 786/4885SMN1; SMN2 829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback